Enrichment of circulating tumor-derived extracellular vesicles from human plasma
…breast cancer (TNBC). As a test case, we examined PD-L1, an immune checkpoint ligand known to be expressed in some tumor tissues, to demonstrate enrichment for EpCAM+ EVs. For this…
read more